NCT04447118 — Non-squamous NSCLC trial site landscape

Public-registry site landscape for NCT04447118, a Non-squamous NSCLC study sponsored by Jiangsu HengRui Medicine Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT04447118 (registry record)
Sponsor	Jiangsu HengRui Medicine Co., Ltd.
Condition(s)	Non-squamous NSCLC; HER2 Exon 20 Mutation
Phase	PHASE3
Listed sites	102
Site countries	United States, Australia, Belgium, China, France, Germany, Italy, Poland, Russia, South Korea, Spain, Taiwan

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT04447118 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.